Hot filament chemical vapour deposition and wear resistance of diamond films on WC-Co substrates coated using PVD-arc deposition technique

Different Cr- and Ti-base films were deposited using PVD-arc deposition onto WC-Co substrates, and multilayered coatings were obtained from the superimposition of diamond coatings, deposited on the PVD interlayer using hot filament chemical vapour deposition (HFCVD). The behaviour of PVD-arc deposited CrN and CrC interlayers between diamond and WC-Co substrates was studied and compared to TiN, TiC, and Ti(C,N) interlayers. Tribological tests with alternative sliding motion were carried out to check the multilayer (PVD+ diamond) film adhesion on WC-Co substrate. Multilayer films obtained using PVD arc, characterised by large surface droplets, demonstrated good wear resistance, while diamond deposited on smooth PVD TiN films was not adherent. Multilayered Ti(C,N)+diamond film samples generally showed poor wear resistance. Diamond adhesion on Cr-based PVD coatings deposited on WC-Co substrate was good. In particular, CrN interlayers improved diamond film properties and 6 gm-thick diamond films deposited on CrN showed excellent wear behaviour characterised by the absence of measurable wear volume after sling tests. Good diamond adhesion on Cr-based PVD films has been attributed to chromium carbide formation on PVD film surfaces during the CVD process. (c) 2005 Elsevier B.V. All rights reserved

Microstructural and tribological comparison of HVOF-sprayed and post-treated M-Mo-Cr-Si (M = Co, Ni) alloy coatings

High velocity oxygen-fuel (HVOF)-sprayed wear resistant Co-28%Mo-17%Cr-3%Si and Ni-32%Mo-15%Cr-3%Si coatings, both as-sprayed and after heat treatments at 600 degrees C for 1 h, have been studied. Particularly, their dry sliding wear behaviour has been compared by ball-on-disk tests against different counterbodies (100Cr6 steel and sintered alumina), and differences were discussed based on microstructural characteristics and micromechanical properties (Vickers microindentation and scratch test responses). As-sprayed coatings contain oxide stringers, are mostly amorphous and display rather low Vickers microhardness (about 7.4 GPa for the Co-based and 6.2 GPa for the Ni-based), toughness and elastic modulus. Heat-treated ones display sub-micrometric crystalline intermetallics, improving hardness (9.6 GPa and 7.4 GPa, respectively) and elastic modulus. Scratch tests indicate greater brittleness of the Ni-based alloy (higher tendency to cracking). Due to low hardness and toughness, both as-sprayed coatings undergo wear loss against steel and alumina counterparts. The more plastic Co-based alloy undergoes higher adhesive wear against steel and lower abrasive wear against alumina; the situation is reversed for the Ni-based alloy. After heat treatment, the wear loss against steel is very low for both coatings; abrasive wear still occurs against alumina. (c) 2007 Elsevier B.V. All rights reserved

Interspecies activity correlations reveal functional correspondence between monkey and human brain areas.

Evolution-driven functional changes in the primate brain are typically assessed by aligning monkey and human activation maps using cortical surface expansion models. These models use putative homologous areas as registration landmarks, assuming they are functionally correspondent. For cases in which functional changes have occurred in an area, this assumption prohibits to reveal whether other areas may have assumed lost functions. Here we describe a method to examine functional correspondences across species. Without making spatial assumptions, we assessed similarities in sensory-driven functional magnetic resonance imaging responses between monkey (Macaca mulatta) and human brain areas by temporal correlation. Using natural vision data, we revealed regions for which functional processing has shifted to topologically divergent locations during evolution. We conclude that substantial evolution-driven functional reorganizations have occurred, not always consistent with cortical expansion processes. This framework for evaluating changes in functional architecture is crucial to building more accurate evolutionary models

Regular Wine Consumption in Chronic Heart Failure: Impact on Outcomes, Quality of Life, and Circulating Biomarkers

Background-Moderate, regular alcohol consumption is generally associated with a lower risk of cardiovascular events but data in patients with chronic heart failure are scarce. We evaluated the relations between wine consumption, health status, circulating biomarkers, and clinical outcomes in a large Italian population of patients with chronic heart failure enrolled in a multicenter clinical trial. Methods and Results-A brief questionnaire on dietary habits was administered at baseline to 6973 patients enrolled in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) trial. The relations between wine consumption, fatal and nonfatal clinical end points, quality of life, symptoms of depression, and circulating biomarkers of cardiac function and inflammation (in subsets of patients) were evaluated with simple and multivariable-adjusted statistical models. Almost 56% of the patients reported drinking at least 1 glass of wine per day. After adjustment, clinical outcomes were not significantly different in the predefined 4 groups of wine consumption. However, patients with more frequent wine consumption had a significantly better perception of health status (Kansas City Cardiomyopathy Questionnaire score, adjusted P<0.0001), less frequent symptoms of depression (Geriatric Depression Scale, adjusted P=0.01), and lower plasma levels of biomarkers of vascular inflammation (osteoprotegerin and C-terminal proendothelin-1, adjusted P<0.0001, and pentraxin-3, P=0.01) after adjusting for possible confounders. Conclusions-We show for the first time in a large cohort of patients with chronic heart failure that moderate wine consumption is associated with a better perceived and objective health status, lower prevalence of depression, and less vascular inflammation, but does not translate into more favorable clinical 4-year outcomes. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT0033633